MELBOURNE, Australia, Oct. 2, 2025 /PRNewswire/ -- Diagnostics company Nutromics has presented the world's first real-time, continuous data on two critical antibiotics - vancomycin and tobramycin - ...

Forbes contributors publish independent expert analyses and insights. McCullough looks at the challenges and opportunities facing CFOs. Rowan Wilkie has been with Nutromics for over three years and ...

A skin patch from an Aussie start-up promises to eliminate the need for painful blood tests, offering instant diagnoses for conditions from sepsis to heart attacks. Here’s how. Melbourne-based ...

Health tracking technology company Nutromics has closed a $5.7 million funding round, with cornerstone investor Artesian buying into the business for the third time. The company is developing a ...

Melbourne-based Nutromics has developed the technology, which is like a continuous glucose monitor but can be applied to a range of conditions. “We are a platform technology,” chief executive and ...